Skip to main content
. 2023 Jan 4;2023:9990843. doi: 10.1155/2023/9990843

Figure 1.

Figure 1

Effect of DoMRE on SUA and SCr levels. (a) SUA levels after 8 and 12-week oral administration. (b) SCr levels after 8 and 12-week administration. (c) ALT levels after 8 and 12-week administration. (d) AST levels after 8 and 12-week administration. NC, normal control group; MC, model control group; DoMRE-L, low dose of DoMRE group; DoMRE-H, high dose of DoMRE group. The data were expressed as mean ± SD of 8 rats in each group. #P < 0.05; ##P < 0.01, compared with NC group; ∗P < 0.05; ∗∗P < 0.01, compared with MC group.